These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12975494)

  • 1. Mechanism-based modeling of the pharmacodynamic interaction of alphaxalone and midazolam in rats.
    Visser SA; Huntjens DR; van der Graaf PH; Peletier LA; Danhof M
    J Pharmacol Exp Ther; 2003 Nov; 307(2):765-75. PubMed ID: 12975494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroactive steroids differ in potency but not in intrinsic efficacy at the GABA(A) receptor in vivo.
    Visser SA; Gladdines WW; van der Graaf PH; Peletier LA; Danhof M
    J Pharmacol Exp Ther; 2002 Nov; 303(2):616-26. PubMed ID: 12388643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism-based pharmacokinetic-pharmacodynamic modeling of concentration-dependent hysteresis and biphasic electroencephalogram effects of alphaxalone in rats.
    Visser SA; Smulders CJ; Reijers BP; Van der Graaf PH; Peletier LA; Danhof M
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1158-67. PubMed ID: 12183676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo characterization of the pharmacodynamic interaction of a benzodiazepine agonist and antagonist: midazolam and flumazenil.
    Mandema JW; Tukker E; Danhof M
    J Pharmacol Exp Ther; 1992 Jan; 260(1):36-44. PubMed ID: 1309878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo modeling of the pharmacodynamic interaction between benzodiazepines which differ in intrinsic efficacy.
    Mandema JW; Kuck MT; Danhof M
    J Pharmacol Exp Ther; 1992 Apr; 261(1):56-61. PubMed ID: 1560385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic-pharmacodynamic modelling of the EEG effect of alfentanil in rats: assessment of rapid functional adaptation.
    Cox EH; Kuipers JA; Danhof M
    Br J Pharmacol; 1998 Aug; 124(7):1534-40. PubMed ID: 9723968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relevance of arteriovenous concentration differences in pharmacokinetic-pharmacodynamic modeling of midazolam.
    Tuk B; Herben VM; Mandema JW; Danhof M
    J Pharmacol Exp Ther; 1998 Jan; 284(1):202-7. PubMed ID: 9435179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous modeling of the pharmacokinetics and pharmacodynamics of midazolam and diazepam.
    Mould DR; DeFeo TM; Reele S; Milla G; Limjuco R; Crews T; Choma N; Patel IH
    Clin Pharmacol Ther; 1995 Jul; 58(1):35-43. PubMed ID: 7628181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics and EEG effects of midazolam during and after 1-minute, 1-hour, and 3-hour intravenous infusions.
    Greenblatt DJ; Ehrenberg BL; Culm KE; Scavone JM; Corbett KE; Friedman HL; Harmatz JS; Shader RI
    J Clin Pharmacol; 2004 Jun; 44(6):605-11. PubMed ID: 15145968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adaptive changes in the pharmacodynamics of midazolam in different experimental models of epilepsy: kindling, cortical stimulation and genetic absence epilepsy.
    Cleton A; Voskuyl RA; Danhof M
    Br J Pharmacol; 1998 Oct; 125(4):615-20. PubMed ID: 9831893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modelling of the pharmacodynamics and pharmacodynamic interactions of CNS active drugs.
    Danhof M; Mandema JW
    Int J Clin Pharmacol Ther Toxicol; 1992 Nov; 30(11):516-9. PubMed ID: 1490817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of pharmacodynamic interactions between dexmedetomidine and midazolam in the rat.
    Bol CJ; Vogelaar JP; Tang JP; Mandema JW
    J Pharmacol Exp Ther; 2000 Jul; 294(1):347-55. PubMed ID: 10871332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic/pharmacodynamic relationship of benzodiazepines in the direct cortical stimulation model of anticonvulsant effect.
    Hoogerkamp A; Arends RH; Bomers AM; Mandema JW; Voskuyl RA; Danhof M
    J Pharmacol Exp Ther; 1996 Nov; 279(2):803-12. PubMed ID: 8930187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamic analysis of the interaction between tiagabine and midazolam with an allosteric model that incorporates signal transduction.
    Jonker DM; Vermeij DA; Edelbroek PM; Voskuyl RA; Piotrovsky VK; Danhof M
    Epilepsia; 2003 Mar; 44(3):329-38. PubMed ID: 12614388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism-based pharmacodynamic modeling of the interaction of midazolam, bretazenil, and zolpidem with ethanol.
    Tuk B; van Gool T; Danhof M
    J Pharmacokinet Pharmacodyn; 2002 Jun; 29(3):235-50. PubMed ID: 12449497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro, pharmacokinetic, and pharmacodynamic interactions of ketoconazole and midazolam in the rat.
    Kotegawa T; Laurijssens BE; Von Moltke LL; Cotreau MM; Perloff MD; Venkatakrishnan K; Warrington JS; Granda BW; Harmatz JS; Greenblatt DJ
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1228-37. PubMed ID: 12183684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic-pharmacodynamic modeling of electroencephalographic effects of midazolam in eight Chinese men.
    Lu JF; Chen G; Xiang BR; An DK
    Zhongguo Yao Li Xue Bao; 1994 Sep; 15(5):399-403. PubMed ID: 7717060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-dependent EEG effects of zolpidem provide evidence for GABA(A) receptor subtype selectivity in vivo.
    Visser SA; Wolters FL; van der Graaf PH; Peletier LA; Danhof M
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1251-7. PubMed ID: 12604703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased Efficacy of GABAA-receptor modulation by midazolam in the kainate model of temporal lobe epilepsy.
    Liefaard LC; Gunput RA; Danhof M; Voskuyl RA
    Epilepsia; 2007 Jul; 48(7):1378-87. PubMed ID: 17442008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic-pharmacodynamic modeling of the antinociceptive effect of buprenorphine and fentanyl in rats: role of receptor equilibration kinetics.
    Yassen A; Olofsen E; Dahan A; Danhof M
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1136-49. PubMed ID: 15701707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.